PTEN and large cell neuroendocrine carcinoma: Additionally, genetic alterations in the PI3K/AKT/mTOR pathway were detected in 15% of the LCNEC: PIK3CA 3%, PTEN 4%, AKT2 4%, RICTOR 5%, and mTOR 1%.